Box sizes and labels will vary.

IDEXX PRV/ADV gI Ab Test (Outside the U.S.)

Pseudorabies Virus (PRV)/Aujeszky's Disease (ADV)

The IDEXX PRV/ADV gI Ab Test is an immunoassay for the detection of antibodies in swine serum to the gI (gE) antigen of pseudorabies virus (PRV/Aujeszky's disease). The presence of antibodies indicates exposure to field strains of PRV and/or vaccines containing gI antigen. This differential test is intended for use in herd management and pseudorabies eradication applications.

* Availability / Distribution: Outside the U.S. 

 

Contact us

Test details


Features

  • Serum samples
  • Differentiates infected from vaccinated animals (DIVA)
  • Results in less than two hours

Part numbers and sizes

99-09836 (6 plates/strips) 
99-09837 (30 plates/solid)

Pseudorabies Virus (PRV)/Aujeszky's Disease (ADV)

Pseudorabies virus (PRV/Aujeszky’s disease) is caused by a type 1 porcine herpesvirus. Infections with the highest mortality rate are those affecting suckling pigs born to a susceptible sow. Baby pigs in the fatal course of the disease exhibit difficulty breathing, fever, hypersalivation, anorexia, vomiting, diarrhoea, trembling and depression.

Within this age group, the final stages of infection are commonly characterized by ataxia, nystagmus, running fits, intermittent convulsions, coma and death. Death usually occurs 24–48 hours following apparent clinical symptoms. The clinical events of the disease in weaning and fattening pigs are essentially the same, except the course of the disease is usually protracted 4–8 days.

The mortality rate in mature pigs may reach 2%; losses, however, do not usually occur. While the clinical course in pregnant swine is virtually the same as in mature pigs, there is variation due to transplacental infection of foetuses. Transplacental infection with PRV can occur, and depending upon the stage of gestation, one of the following sequelae may occur: resorption, premature expulsion, birth of macerated foetuses, stillbirth, or birth of weak, infected pigs.

An assessment of the exposure to pseudorabies virus via natural infection or vaccine is facilitated by a measurement of antibody in the serum.



* Not all products are available and/or registered in every country.